Newer dopamine quinazolones as anti-parkinsonian agents.
D000818:Animals; D000978:Antiparkinson Agents / Q000138:chemical synthesis*; D001552:Benzazepines / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D055598:Chemical Phenomena; D002621:Chemistry; D005260:Female; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D010080:Oxazoles / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D010095:Oxotremorine / Q000037:antagonists & inhibitors; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors
D000978:Antiparkinson Agents; D001552:Benzazepines; D010080:Oxazoles; D010095:Oxotremorine; D012110:Reserpine